{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:44:33Z","timestamp":1789497873376,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.aohep.2025.102115","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:50:06Z","timestamp":1757573406000},"page":"102115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bidirectional association between chronic liver disease and chronic kidney disease: a longitudinal study based on CHARLS 2011\u20132020 data"],"prefix":"10.1016","volume":"31","author":[{"given":"Yuan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2025.102115_bib0001","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s41182-025-00703-x","article-title":"Global, regional, and national trends in chronic kidney disease burden (1990-2021): a systematic analysis of the global burden of disease in 2021","volume":"53","author":"Chen","year":"2025","journal-title":"Trop Med Health"},{"key":"10.1016\/j.aohep.2025.102115_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.101898","article-title":"Global burden and future trends of metabolic dysfunction-associated steatotic liver disease: 1990-2021 to 2045","author":"Kan","year":"2025","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.aohep.2025.102115_bib0003","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic Health: a Presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.aohep.2025.102115_bib0004","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000828","article-title":"Metabolic dysfunction and alcohol-associated liver disease: a narrative review","author":"Dunn","year":"2025","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.aohep.2025.102115_bib0005","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2025.102115_bib0006","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.aohep.2025.102115_bib0007","article-title":"Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021","volume":"7","author":"Feng","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.aohep.2025.102115_bib0008","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.54707","article-title":"Estimated burden of metabolic dysfunction-associated steatotic liver disease in US adults, 2020 to 2050","volume":"8","author":"Le","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.aohep.2025.102115_bib0009","doi-asserted-by":"crossref","DOI":"10.1111\/dom.16358","article-title":"Global, regional and country-specific burden of chronic kidney disease due to type 1 diabetes mellitus: a systematic analysis of the 2021 global disease burden study","author":"Sun","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.aohep.2025.102115_bib0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00125-007-0897-4","article-title":"Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative\/laser-treated retinopathy in type 2 diabetic patients","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.aohep.2025.102115_bib0011","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1097\/CM9.0000000000001513","article-title":"Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999-2016","volume":"134","author":"Zhang","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.aohep.2025.102115_bib0012","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2025.102115_bib0013","doi-asserted-by":"crossref","DOI":"10.1177\/20406223211048649","article-title":"The association between NAFLD and risk of chronic kidney disease: a cross-sectional study","volume":"12","author":"Cao","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.aohep.2025.102115_bib0014","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s40001-023-01114-6","article-title":"Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)","volume":"28","author":"Roderburg","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.aohep.2025.102115_bib0015","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/s41598-023-27762-6","article-title":"MAFLD and NAFLD in the prediction of incident chronic kidney disease","volume":"13","author":"Kwon","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.aohep.2025.102115_bib0016","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13098-025-01796-4","article-title":"CARDIAL-MS (CArdio-Renal-DIAbetes-Liver-Metabolic Syndrome): a new proposition for an integrated multisystem metabolic disease","volume":"17","author":"Godoy-Matos","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.aohep.2025.102115_bib0017","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41575-023-00880-2","article-title":"Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases","volume":"21","author":"Stefan","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2025.102115_bib0018","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/ckj\/sfab230","article-title":"Prevalence and outcomes of chronic liver disease in patients receiving dialysis: systematic review and meta-analysis","volume":"15","author":"Swift","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.aohep.2025.102115_bib0019","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2025.102115_bib0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/17446651.2025.2492767","article-title":"MAFLD vs. MASLD: a year in review","volume":"20","author":"Jiang","year":"2025","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.aohep.2025.102115_bib0021","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1056\/NEJMra1700312","article-title":"Nutritional management of chronic kidney disease","volume":"377","author":"Kalantar-Zadeh","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2025.102115_bib0022","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the reporting of Observational studies in epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.aohep.2025.102115_bib0023","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ije\/dys203","article-title":"Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS)","volume":"43","author":"Zhao","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.aohep.2025.102115_bib0024","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aohep.2025.102115_bib0025","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.aohep.2025.102115_bib0026","first-page":"e426","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.aohep.2025.102115_bib0027","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.2337\/dc21-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes care"},{"key":"10.1016\/j.aohep.2025.102115_bib0028","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.aohep.2025.102115_bib0029","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16591","article-title":"Association of depressive symptoms with incident cardiovascular diseases in middle-aged and older Chinese adults","volume":"2","author":"Li","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.aohep.2025.102115_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.aohep.2025.102115_bib0031","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2020.08.037","article-title":"Natural history of acute kidney disease in patients with cirrhosis","volume":"74","author":"Tonon","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2025.102115_bib0032","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.14226","article-title":"Chronic kidney disease risk associated with metabolic dysfunction-associated steatotic liver disease: a nationwide cohort study in Korea","author":"Kim","year":"2025","journal-title":"Hepatol Res"},{"key":"10.1016\/j.aohep.2025.102115_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/biom15020213","article-title":"From cardiovascular-Kidney-metabolic syndrome to cardiovascular-renal-hepatic-Metabolic syndrome: proposing an expanded framework","volume":"15","author":"Theodorakis","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.aohep.2025.102115_bib0034","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.124.070535","article-title":"Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in Cardiovascular disease via Modified Delphi approach","volume":"151","author":"Chew","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.aohep.2025.102115_bib0035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41581-019-0172-1","article-title":"Intestinal microbiome and fitness in kidney disease","volume":"15","author":"Meijers","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.aohep.2025.102115_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061245","article-title":"Combined effects of chronic kidney disease and nonalcoholic fatty liver disease on the risk of cardiovascular disease in patients with diabetes","volume":"10","author":"Chung","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.aohep.2025.102115_bib0037","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12933-025-02700-0","article-title":"CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes","volume":"24","author":"Schnell","year":"2025","journal-title":"Cardiovasc Diabetol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:54:26Z","timestamp":1780649666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268125003400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1665268125003400"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102115","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bidirectional association between chronic liver disease and chronic kidney disease: a longitudinal study based on CHARLS 2011\u20132020 data","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102115"}}